ATMP CDMO | Advanced Therapies Contract Manufacturing

Germany Europe

Aenova Group Discover our facility

Headquarter - Location Starnberg

Activity: N/A manufacturing
Uses: N/A
Therapeutic areas: N/A
Certifications: N/A
Services: N/A

Batch Size / Reactor: N/A
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: N/A

United States North America

Advanced Protein Production Discover our facility

GMP-certified protein production as a U.S.-based CDMO, supporting both academic research institutions and biotechnology/pharmaceutical companies.

Activity: N/A manufacturing
Uses: N/A
Therapeutic areas: N/A
Certifications: N/A
Services: N/A

Batch Size / Reactor: N/A
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: N/A

Ireland Europe

Cambrex Waterford (Q1 Scientific) Discover our facility

Q1 Scientific Ltd., a Cambrex Company, provides environmentally controlled cGMP stability storage services for the pharmaceutical, medical device, and life science industries.

Activity: SERVICES manufacturing
Uses: N/A
Therapeutic areas: N/A
Certifications: N/A
Services: Storage, Stability studies design, Stability...

Batch Size / Reactor: N/A
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: N/A

Belgium Europe

Cambrex Liege (Q1 Scientific) Discover our facility

Strategically located in the Li ge region of Belgium, the state-of-the-art cGMP facility provides ICH and custom conditions to meet the specific storage requirements of any pharmaceutical project, with options from -80°C storage up to +50°C, with a full range of humidity control.

Activity: SERVICES manufacturing
Uses: N/A
Therapeutic areas: N/A
Certifications: N/A
Services: Storage, Stability studies design, Stability...

Batch Size / Reactor: N/A
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: N/A

Join to view all

India APAC

CHEMICAL-SYNTHETIC NUTRACEUTICALS SERVICES in APAC Discover our facility

Your trusted CRO/CDMO Partner

Activity: CHEMICAL-SYNTHETIC, NUTRACEUTICALS, SERVICES manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: ISO
Services: N/A

Batch Size / Reactor: Small, Medium
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: N/A

Portugal Europe

Rodon Biologics Discover our facility

Rodon Biologics provides excellence in the development of biopharmaceutical products for third parties.

Activity: Abs (Antibodies), BIOLOGICS, Peptide, protein,... manufacturing
Uses: Investigational
Therapeutic areas: N/A
Certifications: N/A
Services: Upstream, Downstream, Cell line development,...

Batch Size / Reactor: Small, Batch, 1 - 100 L, Fed-batch
DEA: N/A
Toxicity (OEB classification): N/A
BSL: 1, 2
Markets: N/A

Germany Europe

Cambrex Wiesbaden Discover our facility

Our specialist team in Wiesbaden has strong expertise in enzyme screening and developed more than 800 proprietary enzymes of different classes.

Activity: BIOLOGICS, Peptide, protein, hormone & enzyme manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: N/A
Services: Analytical methods development, Storage, R&D,...

Batch Size / Reactor: Small, Medium, Large, 1 - 10 sqm, 10 - 50 sqm, 50...
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: FDA (USA), EMA (EU)

United Kingdom Europe

CARBOGEN AMCIS | Manchester, UK Discover our facility

Discover our cosmetic ingredient manufacturing capabilities, fine chemicals and custom synthesis of pharma intermediates capabilities

Activity: CHEMICAL-SYNTHETIC, SERVICES manufacturing
Uses: N/A
Therapeutic areas: N/A
Certifications: ISO, ECOVADIS, Halal Research Council
Services: R&D, Tech transfer, Analytical methods...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: N/A

Switzerland Europe

APR LAB Discover our facility

Contract Service Unit of a Swiss Biopharmaceutical Company that identifies, develops, and markets novel products in rare and ultra-rare diseases globally.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS, COSMETICS,... manufacturing
Uses: Investigational, Preclinical
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP)
Services: Analytical methods development, R&D, Tech...

Batch Size / Reactor: Small
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: EMA (EU)

United States North America

Cambrex Agawam Discover our facility

Cambrex Agawam offers a full suite of microbiological, analytical, and environmental monitoring services to support pharmaceutical and medical device product development.

Activity: SERVICES manufacturing
Uses: N/A
Therapeutic areas: N/A
Certifications: ISO, FDA (cGMP)
Services: Analytical methods development, Batch...

Batch Size / Reactor: N/A
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): N/A
BSL: 1
Markets: FDA (USA), EMA (EU)

France Europe

CDM Lavoisier Discover our facility

CDM Lavoisier is specialized in the manufacturing of glass ampoules, glass vials and plastic (BFS) ampoules.

Activity: Injectables, FDF / DRUG PRODUCTS manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: N/A
Certifications: EMA (EU GMP)
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: EMA (EU)

United States North America

Aenova Group - Location Greensboro, USA Discover our facility

Competence Center Packaging Solids.

Activity: NUTRACEUTICALS manufacturing
Uses: Investigational, Commercial (Phase IV)
Therapeutic areas: N/A
Certifications: FDA (cGMP), Health Canada (Canada GMP), Halal...
Services: Primary packaging, Storage, Secondary packaging,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: FDA (USA), Health Canada (Canada)

Spain Europe

Sylentis Discover our facility

Oligonucleotide manufacturer

Activity: OLIGONUCLEOTIDES manufacturing
Uses: Investigational, Preclinical, Phase I, Phase II,...
Therapeutic areas: N/A
Certifications: EMA (EU GMP)
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 3 (PDE = 100 - 1,000 µg/day)
BSL: N/A
Markets: FDA (USA), EMA (EU)

Join to view all

Spain Europe

FDF / DRUG PRODUCTS in Europe Discover our facility

A GMP facility fully equipped for R&D and pharmaceutical development. Includes laboratories and a pilot plant for technical and clinical batches of sterile products.

Activity: Injectables, Sterile forms (ophtalmic, nasal,... manufacturing
Uses: Investigational, Preclinical, Phase I, Phase II
Therapeutic areas: N/A
Certifications: EMA (EU GMP)
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2
Markets: EMA (EU)

Spain Europe

VIVEbiotech Discover our facility

Your leading GMP-certified CDMO exclusively dedicated to the production of lentiviral vectors.

Activity: ATMP (Advanced Therapies), GTMP (Gene Therapy),... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), French Service-Public...
Services: Upstream, Downstream, Cell line development, Cell...

Batch Size / Reactor: Small, 1 - 100 L, Medium, 100 - 1000 L, Large,...
DEA: N/A
Toxicity (OEB classification): N/A
BSL: 1, 2
Markets: N/A

Spain Europe

VIVUNT PHARMA Discover our facility

CDMO Sterile Oncology Drugs

Activity: Injectables, FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (L) Antineoplastic and immunomodulating agents
Certifications: EMA (EU GMP)
Services: Batch certification / release, Primary packaging,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: EMA (EU)

Switzerland Europe

Ophtapharm, a Sentiss Company Discover our facility

Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility

Activity: Sterile forms (ophtalmic, nasal, otic), FDF / DRUG... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Services: Analytical methods development, Primary packaging,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: FDA (USA), EMA (EU)

Spain Europe

PHARMALOOP S.L. - a Salvat Company Discover our facility

Fully integrated CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets.

Activity: Sterile forms (ophtalmic, nasal, otic), Oral... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: (S) Sensory organs, (V01) Allergens
Certifications: ISO, EMA (EU GMP), FDA (cGMP)
Services: Analytical methods development, Primary packaging,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day)
BSL: 1
Markets: FDA (USA), EMA (EU)

Spain Europe

Rioja Nature Pharma Discover our facility

CDMO NUTRACEUTICALS/FOOD SUPPLEMENTS

Activity: NUTRACEUTICALS manufacturing
Uses: N/A
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), World Health...
Services: N/A

Batch Size / Reactor: Medium
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: FDA (USA), EMA (EU), NMPA (China), MHRA (UK),...

Germany Europe

BAG Health Care Discover our facility

Parenteral F&F provider for vials in small to mid sized batches.

Activity: Injectables, FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Phase I,...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), World Health Organization (GMP /...
Services: Batch certification / release, Primary packaging,...

Batch Size / Reactor: Small, Medium
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1
Markets: EMA (EU), MHRA (UK), TGA (Australia)

Portugal Europe

CZ Vaccines | Large Scale Plant Portugal Discover our facility

Commercial Scale Facility

Activity: Injectables, Abs (Antibodies), BIOLOGICS, Peptide,... manufacturing
Uses: Investigational, Commercial (Phase IV), Phase II,...
Therapeutic areas: (G) Genito urinary system and sex hormones, (J)...
Certifications: ISO, EMA (EU GMP), World Health Organization (GMP...
Services: Storage, Upstream, Tech transfer, Analytical...

Batch Size / Reactor: Batch, 1 - 100 L, Medium, Fed-batch, 100 - 1000 L,...
DEA: N/A
Toxicity (OEB classification): N/A
BSL: 1, 2
Markets: EMA (EU)

Spain Europe

BDI biotech Production Plant Discover our facility

We work as an R&D department specialized in strain and bioprocess development, scale-up and batches production.

Activity: BIOLOGICS, Peptide, protein, hormone & enzyme, LBP... manufacturing
Uses: Investigational, Preclinical
Therapeutic areas: N/A
Certifications: ISO
Services: Analytical methods development, Storage, CMC...

Batch Size / Reactor: Small, Batch, 1 - 100 L, Medium, Fed-batch, 100 -...
DEA: N/A
Toxicity (OEB classification): N/A
BSL: 1
Markets: FDA (USA), EMA (EU), MHRA (UK), Health Canada...

France Europe

Skyepharma Discover our facility

EXPERT AND INNOVATIVE CDMO COMPLEX ORAL SOLIDS: Fully integrated french CDMO Skyepharma is a key player in drug development and delivery of oral technologies serving the global pharmaceutical, biotech and consumer health industries.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), World Health...
Services: Primary packaging, Storage, R&D, Tech transfer,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): N/A
BSL: N/A
Markets: FDA (USA), EMA (EU), MFDS (South Korea), ANVISA...

Spain Europe

CZ Vaccines | Investigational and Medicinal Products Plant Discover our facility

Clinical Trials Facility

Activity: Cell therapy, ATMP (Advanced Therapies),... manufacturing
Uses: Investigational, Preclinical, Phase I, Phase II,...
Therapeutic areas: (A) Digestive tract and metabolism, (G) Genito...
Certifications: ISO, EMA (EU GMP), World Health Organization (GMP...
Services: Upstream, Tech transfer, Analytical methods...

Batch Size / Reactor: Small, Batch, 1 - 100 L
DEA: N/A
Toxicity (OEB classification): N/A
BSL: 2
Markets: EMA (EU), CDSCO (India), ANVISA (Brazil)

Netherlands Europe

Basic Pharma Manufacturing Discover our facility

Basic Pharma can bring your pharmaceuticals from lab scale to the early clinical phase and beyond. Our state-of-the-art facility, with GMP-compliant clean rooms, is well equipped to offer a wide range of analytical testing and regulatory support. These services are tailored to your specific needs, implementing the relevant quality guidelines at every step along the way.

Activity: Injectables, Sterile forms (ophtalmic, nasal,... manufacturing
Uses: Investigational, Preclinical, Phase I, Phase II,...
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP)
Services: Batch certification / release, Primary packaging,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), MHRA (UK), TGA (Australia)

Spain Europe

CZ Vaccines | Large Scale Plant Spain Discover our facility

Single Use Commercial Scale Facility

Activity: Injectables, Abs (Antibodies), BIOLOGICS, Peptide,... manufacturing
Uses: Investigational, Commercial (Phase IV), Phase III
Therapeutic areas: (G) Genito urinary system and sex hormones, (J)...
Certifications: ISO, EMA (EU GMP), World Health Organization (GMP...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Batch, 1 - 100 L, Medium, Fed-batch, 100 - 1000 L,...
DEA: N/A
Toxicity (OEB classification): N/A
BSL: 1, 2
Markets: EMA (EU)

India APAC

Viswa Laboratories Pvt Ltd Discover our facility

CRAMS/CDMO, APIs, Intermediates and specialty chemicals

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (C) Cardiovascular system, (D) Dermatologicals,...
Certifications: World Health Organization (GMP / HACCP)
Services: R&D, Tech transfer, Pilot plant, Scale-up, Clean...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule III (lower potential for abuse)
Toxicity (OEB classification): 3 (PDE = 100 - 1,000 µg/day)
BSL: 2
Markets: EMA (EU), NMPA (China), CDSCO (India), ANVISA...

Germany Europe

Aenova Group - Location Bad Aibling, Germany Discover our facility

Competence Center Blister packaging Third party packaging High volume plant for effervescents.

Activity: Oral solids / OSD, Oral liquids and semisolids,... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), IFS
Services: R&D, Tech transfer, Primary packaging, Secondary...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU)

Romania Europe

Aenova Group - Location Cornu, Romania Discover our facility

Competence Center and one-stop shop for Soft gelatin capsules and VegaGels®.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS,... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Primary packaging, Secondary packaging, Labeling,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), Health Canada (Canada), TGA (Australia)

Ireland Europe

Aenova Group - Location Killorglin, Ireland Discover our facility

Competence Center for modified release pellets.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS,... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), MFDS/KFDA (Republic of Korea...
Services: N/A

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: EMA (EU), PMDA (Japan), MFDS (South Korea), SFDA...

Spain Europe

Liof Pharma S.L.U. Discover our facility

Reliable CDMO partner for aseptic manufacturing and lyophilization of biologics and injectable drugs.

Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Services: Batch certification / release, Primary packaging,...

Batch Size / Reactor: N/A
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1
Markets: FDA (USA), EMA (EU), MHRA (UK), ANVISA (Brazil),...

Italy Europe

Aenova Group - Location Carugate, Italy Discover our facility

Competence Center Semisolids and non-sterile liquids.

Activity: Oral liquids and semisolids, FDF / DRUG PRODUCTS,... manufacturing
Uses: N/A
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), Roszdravnadzor (Russia GMP),...
Services: Primary packaging, Secondary packaging, Labeling,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: EMA (EU), SFDA (Saudi Arabia), ANVISA (Brazil),...

Germany Europe

Aenova Group - Location Marburg, Germany Discover our facility

Competence Center complex conventional solids and narcotics.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Services: Tech transfer, Primary packaging, Secondary...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), ANVISA (Brazil), Russian...

Germany Europe

Adragos Pharma | Leipzig Discover our facility

Semi-solid and non-sterile liquid pharmaceuticals. With over 100 years of experience, we have a track record of providing first class service and customer focused manufacturing.

Activity: Oral liquids and semisolids, FDF / DRUG PRODUCTS,... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: N/A
Certifications: EMA (EU GMP)
Services: Batch certification / release, Primary packaging,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK),...

United States North America

Cambrex Waltham (Snapdragon Chemistry) Discover our facility

Our team members with Snapdragon Chemistry Inc., a Cambrex Company, specialize in chemical process development and manufacturing services, leveraging state-of-the-art technology to optimize your process and prepare scaled quantities of your product.

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Switzerland Europe

Adragos Pharma | Jura Discover our facility

We specialize in aseptic manufacturing of lyophilized or liquid sterile (bio)pharmaceutical drug products through fill and finish.

Activity: Injectables, BIOLOGICS, Peptide, protein, hormone... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP)
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Italy Europe

Laboratori Alchemia SRL Discover our facility

Our facilities are designed to satisfy production requirements ranging from laboratory scale for synthetically complex products or those which are even unknown in literature, to production levels of several hundred kilograms per year.

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: N/A
Therapeutic areas: N/A
Certifications: EMA (EU GMP), World Health Organization (GMP /...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK),...

Germany Europe

Aenova Group - Location Feldkirchen, Germany Discover our facility

Competence Center Semisolids and Liquids.

Activity: Oral liquids and semisolids, FDF / DRUG PRODUCTS,... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: (D) Dermatologicals, (J) Antiinfectives for...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Roszdravnadzor...
Services: R&D, Tech transfer, Primary packaging, Secondary...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), Russian Health Authorities

Spain Europe

Cultiply Discover our facility

Spanish CDMO that develops production and purification processes for recombinant proteins, enzymes, DNA and other bioderived products.

Activity: Abs (Antibodies), BIOLOGICS, ADC & NDC... manufacturing
Uses: Investigational, Preclinical
Therapeutic areas: N/A
Certifications: ISO
Services: R&D, Upstream, Tech transfer, Downstream, Pilot...

Batch Size / Reactor: Small, Batch, 1 - 100 L, Medium, Fed-batch, 100 -...
DEA: Schedule V (lowest potential for abuse)
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day)
BSL: 1, 2
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Switzerland Europe

Aenova Group - Location Sisseln, Switzerland Discover our facility

Competence Center complex conventional solids.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: ISO, FDA (cGMP), World Health Organization (GMP /...
Services: Tech transfer, Primary packaging, Secondary...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), MFDS (South Korea), Turkish Health...

Germany Europe

Aenova Group - Location Tittmoning, Germany Discover our facility

Competence Center conventional solids high volume plant.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS,... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Primary packaging, Secondary packaging, Labeling,...

Batch Size / Reactor: Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), Health Canada (Canada), TGA...

United States North America

Cambrex Longmont Discover our facility

Cambrex Longmont location specializes in the early development of small molecule pharmaceutical products in a fully integrated drug substance and drug product facility.

Activity: CHEMICAL-SYNTHETIC, Oral solids / OSD, Oral... manufacturing
Uses: Investigational, Preclinical, Phase I, Phase II
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Switzerland Europe

CARBOGEN AMCIS | Vionnaz Discover our facility

Highly Potent APIs development and small-scale cGMP production including chromatography and lyophilization

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Phase I, Phase II,...
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Services: R&D, Analytical methods development, Batch...

Batch Size / Reactor: Small
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Portugal Europe

Sidefarma Discover our facility

Sidefarma is a CMO specialized in the manufacture of small and medium size batches for pharmaceutical companies across the world in regulated markets following European quality.

Activity: Oral solids / OSD, Oral liquids and semisolids,... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), UAE Ministry of Health &...
Services: Batch certification / release, Primary packaging,...

Batch Size / Reactor: Small, Medium
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: EMA (EU), PMDA (Japan), MHRA (UK), Health Canada...

Germany Europe

Aenova Group - Location Gronau, Germany Discover our facility

Competence center for conventional solids and clinical services.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), EDE (UAE),...

Switzerland Europe

CARBOGEN AMCIS | Aarau Discover our facility

Development and medium scale cGMP manufacturing including chromatography

Activity: CHEMICAL-SYNTHETIC, BIOLOGICS, SERVICES manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: ISO, FDA (cGMP), World Health Organization (GMP /...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

France Europe

AdhexPharma SAS Discover our facility

CDMO for transdermal patches and oromucosal films

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS, Topical,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (D) Dermatologicals, (H) Systemic hormonal...
Certifications: ISO, EMA (EU GMP), FDA (cGMP)
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

United States North America

Cambrex Durham Discover our facility

Cambrex Durham is our analytical center of excellence, supporting testing across the entire drug development lifecycle.

Activity: CHEMICAL-SYNTHETIC, SERVICES manufacturing
Uses: Investigational, Preclinical, Phase I, Phase II
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

United Kingdom Europe

Cambrex Edinburgh Discover our facility

Cambrex Edinburgh offers world-class solid form screening programs, including salt screening, polymorph screening, co-crystal screening, crystallization screening, and further specialized screening activities.

Activity: CHEMICAL-SYNTHETIC, SERVICES manufacturing
Uses: N/A
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Storage, Analytical methods development, Batch...

Batch Size / Reactor: N/A
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Italy Europe

Cambrex Milan Discover our facility

Our Cambrex Milan site develops and manufactures proprietary products (generic APIs) and provides contract manufacturing services for intermediates and custom APIs at commercial scale.

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Commercial (Phase IV), Phase II,...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Medium, Large
DEA: Schedule IV (low potential for abuse), Schedule V...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Switzerland Europe

CARBOGEN AMCIS | Neuland Discover our facility

Development and medium scale manufacturing

Activity: CHEMICAL-SYNTHETIC, SERVICES manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: FDA (cGMP), World Health Organization (GMP /...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Join to view all

Belgium Europe

CHEMICAL-SYNTHETIC SERVICES in Europe Discover our facility

Trasis is committed to the development of cutting-edge solutions that help improve the diagnosis and treatment of major diseases among which cancers, neurological and cardiological diseases. This with API synthesis, formulation development and (GMP) manufacturing combined with fill and finish capabilities

Activity: CHEMICAL-SYNTHETIC, SERVICES manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (C) Cardiovascular system, (L) Antineoplastic and...
Certifications: ISO, EMA (EU GMP), FDA (cGMP)
Services: Batch certification / release, CMC regulatory...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2, 3, 4
Markets: FDA (USA), EMA (EU), TGA (Australia)

Sweden Europe

Cambrex Karlskoga Discover our facility

Cambrex Karlskoga features a wide range of flexible manufacturing facilities, including kilo-scale, pilot-scale, and large-scale commercial production plants.

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Commercial (Phase IV), Phase II,...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Medium, Large
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Estonia Europe

Cambrex Tallinn Discover our facility

Our team in Tallin has strong expertise in custom organic syntheses and contract R&D for pharmaceutical and fine chemical industries.

Activity: CHEMICAL-SYNTHETIC, SERVICES manufacturing
Uses: Investigational, Preclinical, Phase I, Phase II
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Join to view all

Germany Europe

FDF / DRUG PRODUCTS in Europe Discover our facility

Your cGMP-compliant CDMO for end-to-end services in the complex oral solids dosage forms field, based in Binzen Germany

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Phase I,...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: EMA (EU GMP), FDA (cGMP)
Services: Analytical methods development, Tech transfer,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1
Markets: FDA (USA), EMA (EU)

France Europe

Adragos Pharma | Livron Discover our facility

Sterile liquids and suppositories manufacturing. We handle more than 100 molecules and provide stability studies, narcotics handling and analytical testing services.

Activity: Injectables, FDF / DRUG PRODUCTS, Topical, mucosal... manufacturing
Uses: Investigational, Commercial (Phase IV)
Therapeutic areas: N/A
Certifications: EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)
Services: Batch certification / release, Primary packaging,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK),...

Spain Europe

53Biologics Production Plant Discover our facility

53Biologics is a Spanish CDMO specialized in decoding biologics production, from DNA to proteins, providing from preclinical to cGMP manufacturing.

Activity: Abs (Antibodies), BIOLOGICS, ADC & NDC... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Services: Upstream, Tech transfer, Analytical methods...

Batch Size / Reactor: Small, Batch, 1 - 100 L, Medium, Fed-batch, 100 -...
DEA: N/A
Toxicity (OEB classification): N/A
BSL: 1, 2
Markets: FDA (USA), EMA (EU), MHRA (UK), Health Canada...

Poland Europe

Mabion cGMP Facility Discover our facility

Mabion is a fully integrated CDMO offering a wide services associated with the development and GMP manufacturing of biotherapeutics, including monoclonal antibodies and any recombinant protein-based products.

Activity: Abs (Antibodies), BIOLOGICS, ADC & NDC... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Services: CMC regulatory support, Upstream, Tech transfer,...

Batch Size / Reactor: Small, Batch, 1 - 100 L, Medium, 100 - 1000 L,...
DEA: Schedule V (lowest potential for abuse)
Toxicity (OEB classification): 3 (PDE = 100 - 1,000 µg/day), 4 / HPAPI (PDE = 10...
BSL: 1, 2, 3
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

France Europe

Cenexi SAS Discover our facility

Accueil Sites Osny. Acquired in 2011, the Osny site specializes in the development and production of highly active solid pharmaceutical forms (hormonal and allergens). This 4,000 m2 pharmaceutical plant located 36 km northwest of Paris employs around a hundred people.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (G) Genito urinary system and sex hormones, (H)...
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Germany Europe

Aenova Group - Location Münster, Germany Discover our facility

Competence Center low-dosed high potent solids (hormones, hormone-like), low-dosed capsules.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS, Inhalation... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (H) Systemic hormonal preparations excl. sex...
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Services: Primary packaging, Secondary packaging, Labeling,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), MFDS (South Korea), Turkish...

United States North America

Cambrex High Point Discover our facility

Cambrex High Point focuses on the development and manufacture of active pharmaceutical ingredients (APIs) to support clinical trials from Phase I to Phase III, as well as small-scale commercial manufacturing.

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Commercial (Phase IV), Phase I,...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Japan APAC

Adragos Pharma | Kawagoe Discover our facility

Our facility provides best-in-class manufacturing of tablets and ampoules, English and Japanese outstanding customer service, and has more than 330 high skilled employees. It stands out as one of Japan largest cold storage warehouses.

Activity: Injectables, Oral solids / OSD, FDF / DRUG... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), PMDA/MHLW (Japan GMP)
Services: Storage, CMC regulatory support, Analytical...

Batch Size / Reactor: Large
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

China APAC

Bioworkshops Discover our facility

Integrated development and cGMP manufacturing site

Activity: Abs (Antibodies), BIOLOGICS, ADC & NDC... manufacturing
Uses: Investigational, Preclinical, Phase I, Phase II,...
Therapeutic areas: N/A
Certifications: NMPA (China GMP)
Services: Upstream, Tech transfer, Analytical methods...

Batch Size / Reactor: Small, Batch, 1 - 100 L, Medium, Fed-batch, 100 -...
DEA: Schedule V (lowest potential for abuse)
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day)
BSL: 1, 2
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

United States North America

Actylis Eugene Discover our facility

Chemical Process Discovery, Development, cGMP, and Commerical Manufacturing Services.

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, FDA (cGMP)
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium
DEA: Schedule III (lower potential for abuse), Schedule...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), MHRA (UK), Health Canada...

Italy Europe

Aenova Group - Location Latina, Italy Discover our facility

Competence Center animal health products and sterile technologies.

Activity: Injectables, Sterile forms (ophtalmic, nasal,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2
Markets: FDA (USA), EMA (EU), Turkish Health Authorities,...

Spain Europe

Laboratorio REIG JOFRE, SA (TOLEDO PLANTS) Discover our facility

Betalactam antibiotics (FDF) development and manufacturing state-of-the-art facilities.

Activity: Injectables, Oral solids / OSD, Oral liquids and... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (J) Antiinfectives for systemic use
Certifications: EMA (EU GMP), ECOVADIS, World Health Organization...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Medium, Large
DEA: Schedule V (lowest potential for abuse)
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1
Markets: EMA (EU), MHRA (UK), TGA (Australia), ANVISA...

United States North America

Cambrex Charles City Discover our facility

Our 400+ team members in Charles City specialize in late-phase and commercial API development and cGMP manufacturing.

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Germany Europe

ChemCon GmbH Discover our facility

Contract development and manufacturing partner located in Germany for APIs and fine chemicals specialized in transferring R&D projects into fully cGMP-compliant manufacturing processes.

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: (C) Cardiovascular system, (N) Nervous system, (R)...
Certifications: EMA (EU GMP), FDA (cGMP), ECOVADIS
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Germany Europe

Aenova Group - Location Regensburg, Germany Discover our facility

Competence Center high potent solids (oncology) conventional solids - specialty semisolids & liquids.

Activity: Oral solids / OSD, Oral liquids and semisolids,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Services: R&D, Tech transfer, Analytical methods...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MFDS (South...

France Europe

Cenexi Hérouville Saint Clair Discover our facility

The Hérouville-Saint-Clair site, located near Caen, in Normandy, specializes in the manufacture and filling of injectable and non-injectable sterile liquid products. It has a pharmaceutical surface area of 17,900 m2 over 10 hectares and employs 290 people.

Activity: Injectables, Sterile forms (ophtalmic, nasal,... manufacturing
Uses: Investigational, Commercial (Phase IV), Phase III
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: EMA (EU GMP), FDA (cGMP), NMPA (China GMP), ANVISA...
Services: Batch certification / release, Primary packaging,...

Batch Size / Reactor: Small, Medium
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

China APAC

Pharmaron API Commercial Synthesis Shaoxing (China) Discover our facility

Commercial API Small Molecules /Peptides Synthesis

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, FDA (cGMP), NMPA (China GMP)
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), NMPA (China)

France Europe

Cenexi SAS Discover our facility

GMP plant on a four-hectare site is located 9 km east of Paris. It is a center of excellence for injectable ampoules.

Activity: Injectables, Oral solids / OSD, FDF / DRUG... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: EMA (EU GMP), FDA (cGMP), NMPA (China GMP), ANVISA...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day)
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

China APAC

Apeloa Pharmaceutical Co., Ltd. Discover our facility

Apeloa CDMO provides world-class discovery, development, and manufacturing services for Active Pharmaceutical Ingredients (APIs), Intermediates, and Registered Starting Materials (RSMs).

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), ECOVADIS, World...
Services: Analytical methods development, Primary packaging,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 4 / HPAPI (PDE = 10 - 100 µg/day), 5 / HPAPI (PDE...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Spain Europe

HISTOCELL S.L. | Cell Therapy, Exosomes & Secretomes Discover our facility

Histocell is a Spanish CDMO that develops and manufactures cell therapies from iPSCs, MSCs, secretomes, exosomes and other type of cells, as well medical devices and dermocosmetics.

Activity: Cell therapy, ATMP (Advanced Therapies),... manufacturing
Uses: Investigational, Preclinical, Phase I, Phase II,...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, EMA (EU GMP)
Services: Upstream, Tech transfer, Analytical methods...

Batch Size / Reactor: Small, 1 - 100 L, Medium
DEA: N/A
Toxicity (OEB classification): N/A
BSL: 1, 2
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

FDF / DRUG PRODUCTS BIOLOGICS COSMETICS SERVICES in Europe

Join to view all

United States North America

CHEMICAL-SYNTHETIC in North America Discover our facility

The CDMO company designs, develops, and manufactures new chemical entities to treat human disease. Our cGMP suites support startups to global enterprises across clinical and commercial API production. Scientist-led and regulatory-savvy, we guide you through IND, CMC, ICH, FDA, and ISO challenges.

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, FDA (cGMP), NSF
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2
Markets: FDA (USA)

Spain Europe

Grifols International | Murcia Plant Discover our facility

Sterile manufacturing solutions (small molecules) in flexible bags

Activity: Injectables, FDF / DRUG PRODUCTS manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Primary packaging, Storage, Parametric release,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule III (lower potential for abuse), Schedule...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), TGA (Australia), MFDS (South...

China APAC

SINOWAY INDUSTRIAL CO., LTD Discover our facility

One-stop CDMO Solutions for APl and Key intermediates.

Activity: Injectables, CHEMICAL-SYNTHETIC, ATMP (Advanced... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, FDA (cGMP), World Health Organization (GMP /...
Services: R&D, Pilot plant, Scale-up, Formulation mixing,...

Batch Size / Reactor: Batch, 1 - 100 L, Fed-batch, 100 - 1000 L, Large,...
DEA: Schedule III (lower potential for abuse), Schedule...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day)
BSL: 1, 2, 3, 4
Markets: NMPA (China)

Switzerland Europe

Aenova Group - Location Kirchberg, Switzerland Discover our facility

Competence Center Soft gelatin capsules.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS, COSMETICS,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Services: R&D, Tech transfer, Primary packaging, Secondary...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), TGA (Australia), MFDS (South...

Spain Europe

HIPRA BIOTECH SERVICES | Aiguaviva Discover our facility

End-to-end internal capabilities from cell line development to commercial manufacturing.

Activity: Abs (Antibodies), BIOLOGICS, Peptide, protein,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Upstream, Tech transfer, Analytical methods...

Batch Size / Reactor: Small, Batch, 1 - 100 L, Medium, Fed-batch, 100 -...
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

United States North America

Pharmaron API Commercial Synthesis Coventry (US) Discover our facility

Commercial API Small Molecules Synthesis

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, FDA (cGMP), ECOVADIS
Services: Tech transfer, Pilot plant, Scale-up, Process...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Spain Europe

HIPRA BIOTECH SERVICES | Amer Discover our facility

End-to-end internal capabilities from cell line development to commercial manufacturing

Activity: Injectables, Abs (Antibodies), BIOLOGICS, Peptide,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Upstream, Tech transfer, Analytical methods...

Batch Size / Reactor: Small, Batch, 1 - 100 L, Medium, Fed-batch, 100 -...
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Germany Europe

Adragos Pharma | Athens Discover our facility

Specializes in the development of Value Added Medicines and has been recently upgraded with HPAPI capabilities.

Activity: Injectables, Sterile forms (ophtalmic, nasal,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: N/A
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Spain Europe

Laboratorio REIG JOFRE, SA (BARCELONA PLANT) Discover our facility

Injectable (lyo and liquid) and Liquid manufacturing facilities

Activity: Injectables, Oral liquids and semisolids, FDF /... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: EMA (EU GMP), Health Canada (Canada GMP),...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Medium, Large
DEA: Schedule III (lower potential for abuse), Schedule...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2, 3
Markets: EMA (EU), PMDA (Japan), MHRA (UK), TGA...

United States North America

Lannett CDMO Discover our facility

Lannetts main manufacturing site sits in Seymour, Indiana, and includes capabilities for Oral Solid Dose (OSD) and Liquids.

Activity: Oral solids / OSD, Oral liquids and semisolids,... manufacturing
Uses: Investigational, Commercial (Phase IV), Phase II,...
Therapeutic areas: (C) Cardiovascular system, (H) Systemic hormonal...
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Spain Europe

Grifols International | Barcelona Plant Discover our facility

Sterile manufacturing solutions (small molecules) in flexible bags and vials.

Activity: Injectables, FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule III (lower potential for abuse), Schedule...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK),...

Norway Europe

Adragos Pharma | Halden Discover our facility

We specialize in the manufacturing of IV bags, plastic ampoules and vials using Blow-Fill-Seal (BFS) technology and other dosage forms.

Activity: Injectables, Sterile forms (ophtalmic, nasal,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (D)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Services: Batch certification / release, Primary packaging,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Austria Europe

Lukas Heil-Betriebsstätte Discover our facility

LUKAS Heil-Betriebsstätte GmbH operates a high-performance production facility that complies with the latest GMP standards for sterile and aseptic liquids, particularly glass ampoules.

Activity: CHEMICAL-SYNTHETIC, BIOLOGICS, OLIGONUCLEOTIDES,... manufacturing
Uses: Investigational, Commercial (Phase IV)
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)
Services: N/A

Batch Size / Reactor: Small, Medium
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1
Markets: EMA (EU), PMDA (Japan), MHRA (UK), MFDS (South...

France Europe

Unither Pharmaceuticals Discover our facility

Make affordable healthcare solutions that improve and simplify patients lives

Activity: Injectables, Sterile forms (ophtalmic, nasal,... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Medium, Large
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): N/A
BSL: 1, 2
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Spain Europe

i+Med | Drug products, Cosmetics, Nutraceutics & Medical Devices Discover our facility

Developer and manufacturer of new drug products with control realease technologies.

Activity: Injectables, Sterile forms (ophtalmic, nasal,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (D)...
Certifications: ISO
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2, 3, 4
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Belgium Europe

Cenexi Laboratoires Thissen Discover our facility

This 8,000 m2 plant, with buildings dotted around a site of nearly seven hectares, is located 20 km south of Brussels and has 340 employees*. It specializes in the production of sterile highly potent injectables, mainly against cancer.

Activity: Injectables, FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (G) Genito urinary system and sex hormones, (H)...
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule II (high potential for abuse / medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2, 3, 4
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Join to view all

Spain Europe

FDF / DRUG PRODUCTS CHEMICAL-SYNTHETIC SERVICES in Europe Discover our facility

Solutions for non Viral Delivery programs

Activity: Injectables, CHEMICAL-SYNTHETIC, Sterile forms... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Services: Tech transfer, CMC regulatory support, R&D, Pilot...

Batch Size / Reactor: Small, Medium
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2, 3
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Switzerland Europe

CARBOGEN AMCIS | Bubendorf Discover our facility

Development and cGMPmanufacturing of Highly Potent API including Antibody Drug Conjugates (ADC)

Activity: CHEMICAL-SYNTHETIC, BIOLOGICS, ADC & NDC... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

China APAC

CARBOGEN AMCIS | Shanghai, China Discover our facility

Large scale manufacturing.

Activity: CHEMICAL-SYNTHETIC, SERVICES manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: NMPA (China GMP), ANVISA (Brazil B-GMP)
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

United States North America

Adare Pharma | US Discover our facility

Adare Pharma is a global CDMO with sites in US and EU providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare s proprietary technology platforms specialize in ODT s, taste masking and customized drug release.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: N/A
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

United Kingdom Europe

Pharmaron API Commercial Synthesis Cramlington (UK) Discover our facility

Commercial API Small Molecules Synthesis

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Join to view all

India APAC

FDF / DRUG PRODUCTS CHEMICAL-SYNTHETIC in APAC Discover our facility

Synfine Drugs

Activity: CHEMICAL-SYNTHETIC, FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV)
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: N/A

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule III (lower potential for abuse), Schedule...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Italy Europe

Adare Pharma | EU Discover our facility

Adare Pharma is a global CDMO with sites in US and EU providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare s proprietary technology platforms specialize in ODT s, taste masking and customized drug release.

Activity: Oral solids / OSD, FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: N/A
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Join to view all

Spain Europe

FDF / DRUG PRODUCTS in Europe Discover our facility

Developer and manufacturer of human medicinal products.

Activity: Sterile forms (ophtalmic, nasal, otic), Oral... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Tech transfer, Batch certification / release,...

Batch Size / Reactor: Small, Medium, Large
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day)
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

India APAC

Shilpa Biologicals Private Limited Discover our facility

Shilpa Biologicals is a CDMO which support Process Development, Gene to Cell Line Development to GMP to Formulation Development, Analytical Development, Process Development, Drug Substance, Drug Product, Fill-Finish and Packaging

Activity: Abs (Antibodies), BIOLOGICS, ADC & NDC... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO
Services: Storage, CMC regulatory support, Upstream, Tech...

Batch Size / Reactor: Small, Batch, 1 - 100 L, Medium, Fed-batch, 100 -...
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2, 3
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

France Europe

CARBOGEN AMCIS | Saint-Beauzire Discover our facility

Custom formulation development and GMP sterile manufacture of liquid and lyophilized drug product

Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV)
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: N/A

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Join to view all

India APAC

FDF / DRUG PRODUCTS SERVICES in APAC Discover our facility

Block A, established in 1999, houses production lines for a diverse array of sterile products including Ophthalmic Drops, Pre-filled Syringes, Sterile Eye Ointments, Ampoules, and Inhaled AnesthesiaBlock B, constructed in 2019, features lines for Liquid Vials and Lyophilization, Liquid Ampoules, and Sterile Dry Powder filling.Block C, also built in 2019, serves as the hub for our Quality Assurance, Quality Control, and Administration departments.

Activity: Injectables, FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (C)...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule III (lower potential for abuse), Schedule...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: EMA (EU), MHRA (UK), Health Canada (Canada), TGA...

Spain Europe

MENADIONA S.L Discover our facility

Contract development and manufacturing partner located in Spain for APIs, Intermediates and fine chemicals specialized in transferring R&D projects into fully cGMP-compliant manufacturing processes.

Activity: CHEMICAL-SYNTHETIC, COSMETICS, NUTRACEUTICALS,... manufacturing
Uses: Commercial (Phase IV)
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), ECOVADIS, World...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Medium, Large
DEA: Schedule IV (low potential for abuse), Schedule V...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: N/A
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

Netherlands Europe

CARBOGEN AMCIS | Veenendaal Discover our facility

Large scale manufacturing of Cholesterol and Vitamin D analogs.

Activity: CHEMICAL-SYNTHETIC, SERVICES manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Analytical methods development, Batch...

Batch Size / Reactor: Small
DEA: N/A
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

China APAC

Sichuan Huiyu Pharmaceuticals Co., Ltd. - Formulation Manufacturing Site Discover our facility

As one of Huiyu Pharmaceutical s three core facilities alongside our R&D Center and API Manufacturing Site the Formulation Manufacturing Site is dedicated to the development and production of complex and high-value dosage forms.

Activity: Injectables, Sterile forms (ophtalmic, nasal,... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2, 3, 4
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

China APAC

Sichuan Huiyu Pharmaceuticals Co., Ltd. - API Manufacturing Site Discover our facility

As one of Huiyu Pharmaceutical s three core sites, alongside the R&D center and formulation plant, our API manufacturing facility plays a vital role in our integrated supply chain.

Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2, 3, 4
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

China APAC

Sichuan Huiyu Pharmaceuticals Co., Ltd. - R&D Site Discover our facility

As one of Huiyu Pharma s three core facilities, alongside the API Manufacturing Site and Formulation Manufacturing Site, the R&D Center plays a pivotal role in supporting the development of both APIs and finished dosage forms.

Activity: Injectables, CHEMICAL-SYNTHETIC, Sterile forms... manufacturing
Uses: Investigational, Preclinical, Commercial (Phase...
Therapeutic areas: (A) Digestive tract and metabolism, (B) Blood and...
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Services: Tech transfer, Analytical methods development,...

Batch Size / Reactor: Small, Medium, Large
DEA: Schedule I (high potential for abuse / no medical...
Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE =...
BSL: 1, 2, 3, 4
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China),...

ATMP CDMO Companies | Advanced Therapies Contract Manufacturing Services

Your Trusted Partners for Advanced Therapies Contract Manufacturing and Development

How to Choose an ATMP CDMO Company

Key Services Offered by Advanced Therapy Contract Manufacturers

Benefits of Partnering with ATMP CDMO Companies

ATMP CDMO Companies

Related Information

Let MAI CDMO Network Help You Find the Right ATMP CDMO Partner

Contact us

Want to see all the information?

Unleash the full power of MAI CDMO